PTGS2 and neoplasm: One of the mechanisms might be the decrease in Bcl-2 expression, as it was shown that PGE2 can activate Bcl-2 expression; thus, by inhibiting COX-2, PGE2 is decreased, and thus Bcl-2 will also decrease, leading to tumor regression [38].